Vista Equity Partners,†a leading investment firm focused on software, data, and technology-enabled businesses, announced its investment in†Allocate Software, the†leading international provider of healthcare workforce management software. The investment will†support the company’s next phase of development product innovation and global expansion.
With over 800 customers and one million staff rostered daily, Allocate serves the largest public and private healthcare institutions around the world by supporting the operational and administrative needs of professionals across all healthcare settings. Allocate’s†best-in-class solutions enable the delivery of safe and effective care at optimal cost by helping healthcare organizations have the right people in the right place at the right time.
“We are thrilled to partner with Vista to accelerate development and investment in our market-leading solutions,” said Dr. Sati Sian, CEO of Allocate. “Vista’s global experience providing product and operational expertise to its portfolio will benefit our company, our employees, and most importantly, our customers. Our products enable healthcare institutions to manage their workforce more efficiently and effectively, ultimately helping them improve patient care. We are excited to continue investing in our strong innovation to further enable our customers’ mission.”
“Allocate’s market-leading platform and products with next-generation technology uniquely address the needs of the healthcare, defense, and maritime sectors,” said Alan Cline, Principal, and Co-Head of the Foundation Fund at Vista. “We are excited to work with the Allocate team to help them continue providing trusted and valued solutions to healthcare providers and professionals across the globe.”
Allocate’s Optima, Time Care, RosterOn and Dynama OneView products provide trusted and valued workforce management solutions to customers across Europe, Australia and the United States. The transaction is†expected to close in the second quarter of this year. Financial terms†have not been disclosed.
